Tonix Pharmaceuticals
TNXP
#9180
Rank
ยฃ0.11 B
Marketcap
ยฃ7.42
Share price
-6.97%
Change (1 day)
-77.71%
Change (1 year)

Revenue for Tonix Pharmaceuticals (TNXP)

Revenue in 2026 (TTM): ยฃ13.09 Million

According to Tonix Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ13.18 Million. In 2025 the company made a revenue of ยฃ9.73 Million an increase over the revenue in the year 2024 that were of ยฃ8.04 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Tonix Pharmaceuticals from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ13.09 M34.58%
2025 ยฃ9.73 M21%
2024 ยฃ8.04 M31.92%
2023 ยฃ6.09 M
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Aerie Pharmaceuticals
AERI
ยฃ0.16 B 1,118.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
ยฃ0.19 B 1,367.03%๐Ÿ‡บ๐Ÿ‡ธ USA